시장보고서
상품코드
1684420

세계의 인플루엔자 신속 진단 검사 시장 : 종류별, 제품 종류별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Rapid Influenza Diagnostic Tests Market, By Type, By Product Type, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 369 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

인플루엔자 신속 진단 검사 시장 규모는 2024년 13억 9,678만 달러로 2025년부터 2032년까지 CAGR 5.2%로 확대될 전망입니다.

인플루엔자 신속 진단 검사 시장 역학

독감 및 호흡기질환의 유행과 POC 검사에 대한 수요 증가로 시장 수요가 증가할 것으로 예상됩니다.

인플루엔자 신속 진단 검사 시장의 성장을 촉진하는 주요 요인 중 하나는 전 세계적으로 계절성 독감 발생률이 증가하고 있다는 점입니다. 세계보건기구(WHO)에 따르면, 독감은 매년 수백만 명을 감염시키고, 특히 소아, 노인, 만성질환자 등 고위험군에게 심각한 합병증, 입원, 사망을 유발하고 있으며, COVID-19의 대유행으로 호흡기 감염에 대한 우려도 높아져 독감 및 다른 바이러스성 질환을 구별할 수 있는 신속 진단 솔루션에 대한 수요도 증가하고 있습니다. 질병통제예방센터(CDC)와 세계보건기구(WHO)와 같은 기관의 캠페인은 적시에 검사와 백신 접종을 장려하여 RIDT에 대한 수요를 증가시키고 있습니다. 또한, 보편적 의료보험 제도와 신흥국의 진단 시설에 대한 접근성 개선은 시장 개척을 더욱 촉진하고 있습니다.

현장 검사(POC)로의 전환은 중요한 시장 촉진요인이며, 의료진과 환자들은 보다 빠르고, 접근성이 뛰어나며, 비용 효율적인 진단 솔루션을 원하고 있습니다. 원격지 의료에 적합합니다. 자가 검사 키트의 편리함도 지지받고 있으며, 시장 성장을 더욱 촉진하고 있습니다. 중합효소 연쇄 반응(PCR) 검사에 비해 RIDT는 저렴하고, 빠르고, 간편하여 집단 검진 프로그램이나 일상적인 진단에 적합하며, RIDT의 저렴한 가격과 빠른 납기는 실험실 기반 검사에 대한 접근성이 제한적인 저자원 환경에서 특히 유용합니다.

인플루엔자 신속 진단 검사 시장 : 주요 인사이트

당사의 연구 분석가들의 분석에 따르면, 세계 시장은 예측 기간(2025-2032년) 동안 약 5.2%의 CAGR로 매년 성장할 것으로 예상됩니다.

유형별로는 인플루엔자 A형 부문이 조기 진단에 대한 높은 수요로 인해 2024년 가장 큰 시장 점유율을 차지할 것으로 예측되었습니다.

제품 유형별로는 진단 검사 및 AI 솔루션의 발전으로 인해 디지털 검사 부문이 2024년 주요 제품 유형 부문으로 부상했습니다.

최종 용도별로는 병원 등 의료시설의 신속한 진단에 대한 수요가 높아 2024년에는 병원 부문이 가장 높은 비중을 차지했습니다.

지역별로는 북미가 2024년 매출을 주도했는데, 이는 정부의 지원책과 새로운 POC 검사 개발 등에 기인합니다.

인플루엔자 신속 진단 검사 시장 : 세분화 분석

세계 인플루엔자 신속 진단 검사 시장은 유형, 제품 유형, 최종 용도 및 지역에 따라 세분화됩니다.

시장은 유형에 따라 A형 독감과 B형 독감으로 나뉘는데, A형 독감의 높은 유행률과 조기 진단 솔루션의 필요성이 이 분야의 수요를 증가시킬 것으로 예상됩니다.

시장은 제품 유형에 따라 디지털 진단 검사와 기존 진단 검사 두 가지로 분류됩니다. 디지털 진단 검사 분야는 신속한 독감 진단 검사를 위해 병원에서 디지털 플랫폼의 도입이 진행되고 있어 가장 큰 점유율을 차지할 것으로 예상됩니다.

시장은 최종 용도에 따라 병원, 진단센터, 조사 등 세 가지로 분류됩니다. 병원 분야는 최종 사용 분야에서 가장 높은 점유율을 차지하고 있습니다. 호흡기질환의 유병률 증가와 병원 치료의 필요성이 시장 성장을 견인하고 있습니다.

인플루엔자 신속진단 검사 시장 : 지역별 분석

인플루엔자 신속 진단 검사 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 북미가 독감 신속진단키트 시장을 독점하고 있습니다. 이러한 우위는 주로 양질의 의료에 대한 정부의 지원과 독감 대책에 대한 관심이 높아졌기 때문입니다. 아시아태평양은 RIDT의 급성장 시장으로 부상하고 있습니다. 의료비 증가, 독감 조기 진단 및 치료에 대한 인식 증가, 독감 환자 증가 등의 요인이 이러한 성장에 기여하고 있습니다. 그러나 고급 진단 도구에 대한 접근성 제한과 경제적 제약은 이 지역 시장의 빠른 성장을 저해할 수 있는 요인으로 작용할 수 있습니다.

인플루엔자 신속 진단 검사 시장 : 경쟁 상황

인플루엔자 신속 진단 검사 시장은 주요 업체들 간의 치열한 경쟁으로 형성되고 있습니다. 이 시장은 기술 발전, 주요 기업들의 전략적 이니셔티브, 신속하고 정확한 독감 진단에 대한 수요 증가 등을 배경으로 강력한 성장세를 보이고 있습니다. 독감에 대한 복합 검사 도입으로 각 업체들은 새로운 제품 개발에 박차를 가하고 있습니다. 독감이나 COVID-19 등 여러 호흡기 병원체를 동시에 검출할 수 있는 검사의 개발이 활발히 이루어지고 있습니다. 이러한 멀티플렉스 검사는 진단 효율과 환자 관리를 향상시킵니다.

목차

제1장 인플루엔자 신속 진단 검사 시장 개요

  • 조사 범위
  • 시장 추정 기간

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 인플루엔자 신속 진단 검사의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 인플루엔자 신속 진단 검사 시장 : 산업 분석

  • PEST 분석
  • Porter's Five Forces 분석
  • 시장 성장 전망 : 매핑
  • 규제 체제 분석

제5장 인플루엔자 신속 진단 검사 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아·우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 인플루엔자 신속 진단 검사 시장 상황

  • 인플루엔자 신속 진단 검사 시장 점유율 분석(2024년)
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 인플루엔자 신속 진단 검사 시장 : 종류별

  • 개요
    • 부문별 점유율 분석 : 종류별
    • A형 인플루엔자
    • B형 인플루엔자

제8장 인플루엔자 신속 진단 검사 시장 : 제품 종류별

  • 개요
    • 부문별 점유율 분석 : 제품 종류별
    • 디지털 진단 검사
    • 기존 진단 검사

제9장 인플루엔자 신속 진단 검사 시장 : 최종 용도별

  • 개요
    • 부문별 점유율 분석 : 최종 용도별
    • 병원
    • 진단 센터
    • 조사

제10장 인플루엔자 신속 진단 검사 시장 : 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카(LATAM)
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카(MEA)
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : 인플루엔자 신속 진단 검사 업계

  • 경쟁 대시보드
    • 경쟁 벤치마크
    • 경쟁 포지셔닝
  • 기업 개요
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • MaximBio
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd
    • Hologic, Inc.
    • Luminex Corporation
    • Meridian Bioscience
    • Quidel Corporation
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Sekisui Diagnostics
    • GenMark Diagnostics
    • Alere Inc.
    • Others

제12장 AnalystView의 전방위적 분석

ksm 25.04.15

REPORT HIGHLIGHT

Rapid Influenza Diagnostic Tests Market size was valued at USD 1,396.78 Million in 2024, expanding to a CAGR of 5.2% from 2025 to 2032.

Rapid Influenza Diagnostic Tests (RIDTs) are quick tests used to detect influenza (flu) viruses in respiratory specimens. These tests can provide results within 10-15 minutes and are commonly used in clinics, hospitals, and doctor's offices to help diagnose flu infections.

Rapid Influenza Diagnostic Tests Market- Market Dynamics

The increasing prevalence of influenzas & respiratory diseases and the need for POC testing is expected to propel market demand

One of the primary factors driving the growth of the rapid influenza diagnostic tests market is the increasing incidence of seasonal influenza outbreaks worldwide. According to the World Health Organization (WHO), influenza affects millions of people annually, leading to severe complications, hospitalizations, and deaths, particularly among high-risk populations such as children, the elderly, and individuals with chronic illnesses. The COVID-19 pandemic has also heightened concerns about respiratory infections, leading to increased demand for rapid diagnostic solutions to differentiate between influenza and other viral diseases. Campaigns by organizations like the Centers for Disease Control and Prevention (CDC) and WHO encourage timely testing and vaccination, thereby boosting the demand for RIDTs. Additionally, initiatives for universal healthcare coverage and improved access to diagnostic facilities in developing countries are further driving market growth.

The shift towards point-of-care (POC) testing is a significant market driver, as healthcare providers and patients seek faster, more accessible, and cost-effective diagnostic solutions. RIDTs provide on-the-spot results within 10-15 minutes, making them ideal for clinics, pharmacies, emergency rooms, and remote healthcare settings. The convenience of self-testing kits is also gaining traction, further fueling market growth. Compared to polymerase chain reaction (PCR) tests, RIDTs are less expensive, quicker, and easier to use, making them a preferred choice for mass screening programs and routine diagnostic use. The affordability and rapid turnaround time of RIDTs are particularly beneficial in low-resource settings, where access to laboratory-based testing is limited.

Rapid Influenza Diagnostic Tests Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.2% over the forecast period (2025-2032)

Based on Type segmentation, the influenza A segment was predicted to show maximum market share in the year 2024, due to the high need for early diagnosis.

Based on Product Type segmentation, the digital tests segment was the leading Product Type segment in 2024, with the advancement in diagnostic testing & AI solutions.

Based on End Use segmentation, the hospitals segment was the leading End Use segment in 2024, owing to the high demand for rapid diagnostics in healthcare facilities such as hospitals.

Based on the region, North America was the leading revenue generator in 2024, owing to supportive government incentives, new POC testing developments, etc.

Rapid Influenza Diagnostic Tests Market- Segmentation Analysis:

The Global Rapid Influenza Diagnostic Tests Market is segmented based on Type, Product Type, End Use, and Region.

The market is divided into two categories based on Type: influenza A and influenza B. The influenza A segment dominates the market. The high prevalence of influenza A and the need for early diagnostic solutions are expected to bolster segment demand.

The market is divided into two categories based on the Product Type: digital diagnostic tests and conventional diagnostic tests. The digital diagnostic tests segment is expected to hold the largest share due to the higher adoption of digital platforms at hospitals for rapid influenzas diagnosis tests.

The market is divided into three categories based on End Use: hospitals, diagnostic centers, and research. The hospitals segment holds the highest share of the End Use segment. The rising prevalence of respiratory diseases and the need for hospital treatment is boosting market growth.

Rapid Influenza Diagnostic Tests Market- Geographical Insights

Across the world, the Rapid Influenza Diagnostic Tests market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the Rapid Influenza Diagnostic Tests market. This dominance is primarily due to government support for high-quality healthcare, and increased focus on influenza control. The Asia-Pacific region is emerging as the fastest-growing market for RIDTs. Factors such as increasing healthcare expenditure, rising awareness about early diagnosis and treatment of influenza, and the growing prevalence of influenza cases contribute to this growth. However, challenges such as limited access to advanced diagnostic tools and economic constraints may hinder rapid market growth in these areas.

Rapid Influenza Diagnostic Tests Market- Competitive Landscape:

The rapid influenza diagnostic tests market is formed by strong competition among key players. The market is experiencing robust growth, driven by technological advancements, strategic initiatives by key players, and the increasing need for rapid and accurate influenza diagnostics. The introduction of combination tests for influenza is enabling companies to develop new products. The development of tests capable of simultaneously detecting multiple respiratory pathogens, such as influenza and COVID-19, is gaining traction. These multiplex tests enhance diagnostic efficiency and patient management.

Recent Developments:

In May 2023, MaximBio secured a contract from the National Institutes of Health (NIH) to develop a new rapid test platform.

In 2024, Siemens AG introduced a new medical diagnostic solution for influenza testing to expand its product portfolio.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RAPID INFLUENZA DIAGNOSTIC TESTS MARKET KEY PLAYERS

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • MaximBio
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Luminex Corporation
  • Meridian Bioscience
  • Quidel Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Sekisui Diagnostics
  • GenMark Diagnostics
  • Alere Inc.
  • Others

GLOBAL RAPID INFLUENZA DIAGNOSTIC TESTS MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Influenza A
  • Influenza B

GLOBAL RAPID INFLUENZA DIAGNOSTIC TESTS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • Digital Diagnostic Tests
  • Conventional Diagnostic Tests

GLOBAL RAPID INFLUENZA DIAGNOSTIC TESTS MARKET, BY END USE- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Diagnostic Centers
  • Research

GLOBAL RAPID INFLUENZA DIAGNOSTIC TESTS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Rapid Influenza Diagnostic Tests Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Rapid Influenza Diagnostic Tests Market Snippet by Type
    • 2.1.2. Rapid Influenza Diagnostic Tests Market Snippet by Product Type
    • 2.1.3. Rapid Influenza Diagnostic Tests Market Snippet by End Use
    • 2.1.4. Rapid Influenza Diagnostic Tests Market Snippet by Country
    • 2.1.5. Rapid Influenza Diagnostic Tests Market Snippet by Region
  • 2.2. Competitive Insights

3. Rapid Influenza Diagnostic Tests Key Market Trends

  • 3.1. Rapid Influenza Diagnostic Tests Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Rapid Influenza Diagnostic Tests Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Rapid Influenza Diagnostic Tests Market Opportunities
  • 3.4. Rapid Influenza Diagnostic Tests Market Future Trends

4. Rapid Influenza Diagnostic Tests Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Rapid Influenza Diagnostic Tests Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Rapid Influenza Diagnostic Tests Market Landscape

  • 6.1. Rapid Influenza Diagnostic Tests Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Rapid Influenza Diagnostic Tests Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Influenza A
    • 7.1.3. Influenza B

8. Rapid Influenza Diagnostic Tests Market - By Product Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 8.1.2. Digital Diagnostic Tests
    • 8.1.3. Conventional Diagnostic Tests

9. Rapid Influenza Diagnostic Tests Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic Centers
    • 9.1.4. Research

10. Rapid Influenza Diagnostic Tests Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Rapid Influenza Diagnostic Tests Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Rapid Influenza Diagnostic Tests Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Rapid Influenza Diagnostic Tests Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Rapid Influenza Diagnostic Tests Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Rapid Influenza Diagnostic Tests Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Rapid Influenza Diagnostic Tests Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Becton, Dickinson and Company
    • 11.2.3. MaximBio
    • 11.2.4. bioMerieux SA
    • 11.2.5. Bio-Rad Laboratories Inc.
    • 11.2.6. Danaher Corporation
    • 11.2.7. F. Hoffmann-La Roche Ltd
    • 11.2.8. Hologic, Inc.
    • 11.2.9. Luminex Corporation
    • 11.2.10. Meridian Bioscience
    • 11.2.11. Quidel Corporation
    • 11.2.12. Siemens Healthineers AG
    • 11.2.13. Thermo Fisher Scientific Inc.
    • 11.2.14. Sekisui Diagnostics
    • 11.2.15. GenMark Diagnostics
    • 11.2.16. Alere Inc.
    • 11.2.17. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제